aztreonam has been researched along with Communicable Diseases, Emerging in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Communicable Diseases, Emerging: Infectious diseases that are novel in their outbreak ranges (geographic and host) or transmission mode.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 31-year-old woman who had developed systemic lupus erythematosus at 17 years of age was admitted to the hospital for suspected cellulitis in the lower extremities." | 1.38 | Recurrent Helicobacter cinaedi cellulitis and bacteremia in a patient with systemic lupus erythematosus. ( Asahara, M; Asako, K; Kawakami, S; Kikuchi, H; Koshio, O; Ono, Y; Tansho, S; Ubagai, T; Ueda, T, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kikuchi, H | 1 |
| Asako, K | 1 |
| Tansho, S | 1 |
| Ueda, T | 1 |
| Koshio, O | 1 |
| Ubagai, T | 1 |
| Asahara, M | 1 |
| Kawakami, S | 1 |
| Ono, Y | 1 |
1 other study available for aztreonam and Communicable Diseases, Emerging
| Article | Year |
|---|---|
Recurrent Helicobacter cinaedi cellulitis and bacteremia in a patient with systemic lupus erythematosus.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacteremia; Cellulitis; Communicable Diseases, Emerging; Fe | 2012 |